Disorders of testicular development (gonadal dysgenesis) from fetal life to the adulthood
pdf (Język Polski)

How to Cite

Słowikowska-Hilczer, J. (2018). Disorders of testicular development (gonadal dysgenesis) from fetal life to the adulthood. Quarterly Journal Fides Et Ratio, 35(3), 152-160. Retrieved from https://fidesetratio.com.pl/ojs/index.php/FetR/article/view/543
Keywords

Abstract

Disorders of testicular development (gonadal dysgenesis) in fetal life are associated with disorders of their hormonal and gametogenic activity in the adulthood. The lack or reduction of testosterone secretion by the fetal Leydig cells lead to disorders in the differentiation of male internal and external genital organs as well as disturbances in the determination of the psychic sex. Abnormal secretion of anti-Müllerian hormone (AMH) by Sertoli cells is associated with the survival of Müllerian ducts and the presence of female internal genitalia in individuals with a male genetic sex. A further clinical consequence of organogenesis disturbances is the development of hypergonadotrophic hypogonadism during the period of expected puberty and lack of fertility. However, in addition to the classic gonadal dysgenesis, which reveals the reverse of sexual characteristics, there are probably its incomplete, latent forms. There are no disorders of sexual differentiation, but "milder" disorders such as cryptorchidism, decreased fertility and increased risk of testicular germ cell tumours (GCT). All of these disorders probably have a common etiology, thus it was proposed to create one clinical syndrome called the testicular dysgenesis syndrome (TDS).

In the last 60 years, there has been a progressive increase in the incidence of disorders belonging to the TDS syndrome. It is believed that they may be caused by pollution of the natural environment as a result of the development of modern civilization. Adverse effects on the male sexual system are primarily caused by the so-called xenoestrogens. They have a variable chemical structure and occur among synthetic substances of industrial, agricultural and medical use. They can bind to the estrogen receptor and mimic the action of estrogens, and can also act as antiandrogens. Some xenoestrogens accumulate in the food network, and thus become potentially harmful not only to living organisms, but also to future generations. Notable involvement in the male fertility disorder is also attributed to environmental factors such as elevated temperature, electromagnetic radiation, chronic stress, obesity, sedentary lifestyle, as well as smoking and alcohol abuse. The consequence of most of these factors is oxidative stress, which is caused by the imbalance between the production of so-called reactive oxygen species (ROS) and the protective antioxidant system responsible for their neutralization and elimination. ROS leads to a reduction in sperm count, impaired function, decreased motility and abnormal morphology and DNA damage, and ultimately impaired fertilization or embryo development. Most environmental factors associated with lifestyle are modifiable. Improvement in the quality of semen and fertility parameters can also be achieved in some cases by using antioxidant substances.

pdf (Język Polski)

References

Bonde J.P., Ernst E., Jensen T.K. i in. (1998), Relation between semen quality and fertility: a population-based study of 430 first-pregnancy planners, Lancet, 352, 1172-1127.
Carlsen E., Giwercman A., Keiding N. i in. (1992). Evidence for decreasing quality of semen during past 50 years. British Medical Bulletin, 305, 467-471.
Delbès G., Levacher C, Habert R. (2006), Estrogen effects on fetal and neonatal testicular development, Reproduction, 132(4), 527-538.
EUROCAT, 2017. http://www.eurocat-network.eu/
Guminska A., Oszukowska E., Kuzanski W. i in. (2010), Less advanced testicular organogenesis is associated with a higher incidence of germ cell neoplasia, International Journal of Andrology, 33, 153-162.
Joensen U.N., Jorgensen N., Rajpert-DeMeyts E. i in. (2008), Testicular Dysgenesis Syndrome and Leydig cell function. Basic & Clinical Pharmacology & Toxicology, 102, 155-161.
Kula K., Słowikowska-Hilczer J. (2003), Konsekwencje zaburzeń działania hormonów płciowych w obrębie centralnego układu nerwowego: zmiany behawioralne, anatomiczne i czynnościowe, Neurologia i Neurochirurgia Polska, 4, 19-39.
Looijenga L.H. (2014), Testicular germ cell tumors, Pediatric Endocrinology Reviews, Suppl 2, 251-262.
Main K.M., Jensen R.B., Asklund C i in. (2006), Low birth weight and male reproductive function, Hormone Research, 65, 116-122.
Mylchreest E., Cattley R.C., Foster P.M.D. (1998), Male reproductive tract malformations in rats following gestational and lactational exposure to di(n-butyl) phthalate: an antiandrogenic mechanisim? Journal of Toxicological Sciences, 43, p. 47-60.
Rajpert-DeMeyts E. (2006), Developmental model for the pathogenesis of testicular carcinoma in situ: genetic and environmental aspects. Human Reproduction Update, 12, 303-323.
Rajpert-DeMeyts E., Hoei-Hansen C.E. (2007), From gonocytes to testicular cancer: the role of impaired gonadal development, Annals of the New York Academy of Sciences, 1120, 168–180.
Skakkebaek N.E., Rajpert-DeMeyts E., Main K.M. (2001), Testicular dysgenesis syndrome: an increasingly common developmental disorder with environmental aspects. Human Reproduction, 16, 972-978.
Słowikowska-Hilczer J. (2006), Xenobiotics with estrogen or antiandrogen action – disruptors of the male reproductive system. Central European Journal of Medicine, 3, 205-227.
Słowikowska-Hilczer J., Hirschberg AL, Claahsen-van der Grinten H i in. (2017), Fertility outcome and information on fertility issues in individuals with different forms of disorders of sex development: findings from the dsd-LIFE study. Fertility and Sterility, 108(5), 822-831.
Słowikowska-Hilczer J., Kula K. (2000), Kliniczne konsekwencje zaburzeń organogenezy jądra i obwodowego działania steroidów płciowych. End. Diab. Chor. Przem. Mat., 6, Supl. 1, 51-56.
Słowikowska-Hilczer J., Szarras-Czapnik M., Marchlewska K., Filipiak E. (2013), Zespół dysgenetycznych jąder: patogeneza i konsekwencje kliniczne, Endokrynologia Pediatryczna, 1(42), 67-76.
Słowikowska-Hilczer J., Szarras-Czapnik M., Wolski J.K. i in. (2015), The risk of neoplasm associated with dysgenetic testes in prepubertal and pubertal/adult patients, Folia Histochem Cytobiol., 53(3), 218-226.
Swan S.H., Elkin E.P., Fenster L. (2000), The question of declining sperm density revisited: an analysis of 101 studies published 1934-1996. Environmental Health Perspectives, 108, 961-966.
Toppari J., Virtanen H.E., Main K.M., Skakkebaek N.E. (2010), Cryptorchidism and hypospadias as a sign of testicular dysgenesis syndrome (TDS): Environmental connection. Birth Defects Research Part A: Clinical and Molecular Teratology, 88, 910-919.
Skakkebaek N.E., Rajpert-De Meyts E., Buck Louis G.M. i in. (2016), Male reproductive disorders and fertility trends: influences of environment and genetic susceptibility, Physiological Reviews, 96(1), 55-97.
Vos J.G., Dybing E., Greim H.A. i in. (2000), Health effects on endocrine-disrupting chemicals on wildlife, with special reference to the European situation. Critical Reviews in Toxicology, 30, 71-133.
Wohlfart-Veje C., Main K.M., Skakkebaek N.E. (2009), Testicular dysgenesis syndrome: foetal origin of adult reproductive problems. Clinical Endocrinology, 71, 459-465.

Downloads

Download data is not yet available.